ENHANCING HEALTHCARE AI MODELS WITH SYNTHETIC DATA: SOLUTIONS FOR LIMITED DATA IN DISEASE PREDICTION AND TREATMENT

This article explores the transformative potential of synthetic data in addressing the challenges of limited data availability in healthcare AI development. It examines various techniques for generating synthetic data, including Generative Adversarial Networks (GANs), Variational Autoencoders (VAEs), and the Synthetic Minority Over-sampling Technique (SMOTE), and their applications in enhancing disease prediction and treatment optimization models. Through case studies, the article demonstrates how synthetic data can improve rare disease diagnosis, optimize clinical trial design, and enhance predictive models for chronic diseases. The discussion encompasses the strengths of synthetic data in healthcare AI, such as addressing data scarcity and privacy concerns, as well as its limitations, including potential biases and validation challenges. The article concludes by outlining future directions for synthetic data in healthcare, emphasizing its role in advancing personalized medicine and fostering more inclusive and collaborative research environments.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-10-21
DOI
https://doi.org/10.5281/zenodo.13963542
Primary Topic
Machine Learning in Healthcare
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ENHANCING HEALTHCARE AI MODELS WITH SYNTHETIC DATA: SOLUTIONS FOR LIMITED DATA IN DISEASE PREDICTION AND TREATMENT

Zenodo (CERN European Organization for Nuclear Research)
Machine Learning in Healthcare
article

ENHANCING HEALTHCARE AI MODELS WITH SYNTHETIC DATA: SOLUTIONS FOR LIMITED DATA IN DISEASE PREDICTION AND TREATMENT

article en

Abstract

This article explores the transformative potential of synthetic data in addressing the challenges of limited data availability in healthcare AI development. It examines various techniques for generating synthetic data, including Generative Adversarial Networks (GANs), Variational Autoencoders (VAEs), and the Synthetic Minority Over-sampling Technique (SMOTE), and their applications in enhancing disease prediction and treatment optimization models. Through case studies, the article demonstrates how synthetic data can improve rare disease diagnosis, optimize clinical trial design, and enhance predictive models for chronic diseases. The discussion encompasses the strengths of synthetic data in healthcare AI, such as addressing data scarcity and privacy concerns, as well as its limitations, including potential biases and validation challenges. The article concludes by outlining future directions for synthetic data in healthcare, emphasizing its role in advancing personalized medicine and fostering more inclusive and collaborative research environments.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 65%
Machine Learning in Healthcare
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

ENHANCING HEALTHCARE AI MODELS WITH SYNTHETIC DATA: SOLUTIONS FOR LIMITED DATA IN DISEASE PREDICTION AND TREATMENT · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS